Quantum-Si incorporated
Financials
Valuation Metrics
Quantum-Si incorporated's Market Cap is $162M. At end of 2025 it was $218M. Ranked #3044 of 3,121 in US market (top 98%), #1400 of 1,463 on NASDAQ (top 96%), #258 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 97%) by Market Cap.
Investment Metrics(as of 2026-09-19)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $162M | US#3,044/3,121 Sec#258/266 |
| Revenue | $2M | US#2,871/3,121 Sec#189/266 |
| Net Income | $-99M | US—/3,121 Sec—/266 |
| Total Assets | $194M | US#3,001/3,121 Sec#247/266 |
| Net Assets | $180M | US#2,715/3,121 Sec#198/266 |
| Employees | 145 | US#2,557/3,121 Sec#149/266 |
| Value | ||
| P/B | 0.90x | US#315/3,121 Sec#10/266 |
| P/S | 101.09x | US#2,949/3,121 Sec#179/266 |
| FCF Yield | -57.74% | US—/3,121 Sec—/266 |
| Profitability | ||
| ROE | -54.67% | US#2,699/3,121 Sec#162/266 |
| ROA | -50.89% | US#2,993/3,121 Sec#216/266 |
| Op. Margin | -5929.72% | US#2,864/3,121 Sec#183/266 |
| Revenue Growth | -52.96% | US#2,746/3,121 Sec#163/266 |
| Financial Health | ||
| Debt Ratio | 7.42% | US#70/3,121 Sec#33/266 |
| Total Debt | $3M | US#2,943/3,121 Sec#229/266 |
| FCF | $-94M | US#2,620/3,121 Sec#137/266 |
| Cash | $24M | US#2,833/3,121 Sec#255/266 |
| Current Ratio | 9.97x | US#259/3,121 Sec#81/266 |
| Performance | ||
| 1Y Return | -51.30% | US#2,778/3,121 Sec#237/266 |
| 1M Return | -3.25% | US#432/3,121 Sec#44/266 |
| From 52W High | -75.96% | US#3,050/3,121 Sec#251/266 |
| 1Y MDD | -73.30% | US#2,998/3,121 Sec#242/266 |
| Trading | ||
| Volume | 1,637,856 shares | US#624/3,121 Sec#59/266 |
| Trading Value | $1M | US#2,887/3,121 Sec#244/266 |
| Per Share | ||
| EPS | $-0.45 | US—/3,121 Sec—/266 |
| BPS | $0.83 | US#2,724/3,121 Sec#209/266 |
Company Info
Quantum-Si incorporated operates within the life sciences sector, focusing on the creation of an advanced platform for individual molecule detection. This innovative technology is designed to streamline sample preparation and subsequent sequencing processes. The company offers a unique, proprietary single molecule detection system that draws on advancements from the semiconductor industry. This system is specifically applied to the field of proteomics, paving the way for next-generation protein sequencing. Established in 2013, Quantum-Si's headquarters are located in Guilford, Connecticut.